Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety.

Noyes, R; DuPont, R L; Pecknold, J C; Rifkin, A; Rubin, R T; Swinson, R P; Ballenger, J C; Burrows, G D

Noyes, R; DuPont, R L; Pecknold, J C; Rifkin, A; Rubin, R T; Swinson, R P; Ballenger, J C; Burrows, G D.

Affiliation

Noyes R; Department of Psychiatry, University of Iowa College of Medicine, Iowa City.

Arch Gen Psychiatry ; 45(5): 423-8, 1988 May.

Article in En | MEDLINE | ID: mdl-3358644

Subject(s)

Agoraphobia/drug therapy; Alprazolam/therapeutic use; Anxiety Disorders/drug therapy; Fear; Panic; Phobic Disorders/drug therapy; Adult; Agoraphobia/psychology; Alprazolam/adverse effects; Anxiety Disorders/psychology; Ataxia/chemically induced; Chemical and Drug Induced Liver Injury/etiology; Fatigue/chemically induced; Female; Humans; Male; Memory Disorders/chemically induced; Patient Compliance; Patient Dropouts; Placebos; Random Allocation; Sleep Stages

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Anxiety Disorders / Panic / Phobic Disorders / Alprazolam / Agoraphobia / Fear Type of study: Clinical_trials / Etiology_studies Limits: Adult / Female / Humans / Male Language: En Journal: Arch Gen Psychiatry Year: 1988 Type: Article

Search on Google

XML

PubMed Links